Amyloidosis

December 5th 2020

New data from an ongoing trial showed patients achieved MRD negative status after a vaccine regimen—and have maintained status over a year.

February 29th 2020

The RareWear program is designed to bridge medical device companies to rare disease patient applicants, seeking better disease and treatment monitoring.

February 29th 2020

New research suggests proposals aimed at reducing out of pocket costs may harm minimally-funded drug developers.

December 14th 2019

The new indication will allow the longtime ALS therapy to be used among the 85% of patients required to use PEG due to dysphagia.